Nuwellis Stock (NASDAQ:NUWE)

Revenue Ownership Financials Chart Transcripts

Previous Close

$3.00

52W Range

$2.73 - $524.65

50D Avg

$14.06

200D Avg

$59.28

Market Cap

$1.04M

Avg Vol (3M)

$106.77K

Beta

0.30

Div Yield

NUWE Company Profile

Nuwellis, Inc., a medical device company, develops, manufactures, and commercializes medical devices used in ultrafiltration therapy. The company provides Aquadex FlexFlow and Aquadex SmartFlow systems, which are used to treat patients suffering from fluid overload due to heart failure, as well as Aquadex SmartFlow system for temporary use in adult and pediatric patients. The company was formerly known as CHF Solutions, Inc. and changed its name to Nuwellis, Inc. in April 2021. Nuwellis, Inc. was founded in 1999 and is headquartered in Eden Prairie, Minnesota.

Industry

Medical - Devices

Sector

Healthcare

Exchange

NASDAQ

ADR

Country

Employees

IPO Date

Feb 16, 2012

Website

NUWE Performance

NUWE Financial Summary

	Dec 25	Dec 24	Dec 23
Revenue	$8.27M	$8.74M	$8.86M
Operating Income	$-11.11M	$-10.99M	$-17.63M
Net Income	$-17.52M	$-11.16M	$-20.21M
EBITDA	$-11.11M	$-10.53M	$-16.36M
Basic EPS	$-25.39	$-8.00	$-360.07
Diluted EPS	$-25.39	$-8.00	$-360.07

Fiscal year ends in Dec 25 | Currency in USD

Latest Earnings Call Transcripts

Q1 26May 12, 26 | 12:00 AM

Q4 25Mar 10, 26 | 9:00 AM

Q2 25Aug 14, 25 | 9:00 AM

Peer Comparison

Ticker	Company
IVF	INVO Fertility, Inc.
OCEA	Ocean Biomedical, Inc.
ACON	Aclarion, Inc.
BACK	IMAC Holdings, Inc.
SABS	SAB Biotherapeutics, Inc.
VINC	Vincerx Pharma, Inc.